Closed
SectorHealthcare
14.08 -2.22
24h
Min
14.08
Max
14.21
Income | -22M -274M |
---|---|
Sales | -5.4M 2.2M |
EPS | -0.29 |
Profit margin | -12,622.627 |
Employees | 750 |
EBITDA | -284K -284M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +15.7% upside |
Market Cap | 1.2B 8.8B |
---|---|
Previous open | 16.3 |
Previous close | 14.08 |
By Acuity
50%
50%
148 / 371 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 16.29 USD 15.7%
High 19 USD
Low 12 USD
Based on 9 Wall Street analysts offering 12 month price targets forRoivant Sciences Ltd - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$